Abstract:263 Background: With the development of endoscopic therapy and the introduction of immunotherapies, it is more important for preserving the esophagus and uninvaded lymph nodes to avoid the damages involving the long-term quality of life and normal immune function caused by esophagectomy with radical lymphadenectomy. Methods: We collected patients with T1 ESCC who underwent endoscopic resection or esophagectomy from 2014 to 2021 in three cancer centers. The primary end point was presence of lymph node metastasis (LNM) in surgical resection specimens or detection of metastases during follow-up. Univariate and multivariate logistic regression were used to screen the clinicopathological features related to LNM. Using the function 'lrm' constructed the prediction model. The area under the curve (AUC) of receiver operating characteristic and calibration graphs were used to assess the performance of the model. An external validation was conducted to evaluate the generalization of the model. We then prospectively collected 28 surgically resected tissue samples of T1 ESCC to further supplement the model from the cellular and molecular level, and used 6 markers (CK, CD34, D2-40, CD4, CD8, FOXP3) and DAPI dye to process multiple immunofluorescence (mIF) staining. Afterwards, we analyzed the density, spatial distribution of microvessels, lymphatic capillaries and tumor-associated immune cells and the interaction between them and malignant cells in the tumor microenvironment of T1 ESCC to explore the relationship between tumor microenvironment and risk of LNM. Results: 1109 patients with T1 ESCC were included. 653 patients from two centers constituted the training cohort, and 456 patients from the third center served as the validation cohort. Multivariate logistic regression based on the training cohort showed that tumor invasion into the submucosa, poor histological grade, and lymphovascular invasion were risk factors for LNM in T1 ESCC. Subsequently, we constructed a model based on three variables to predict the risk of LNM in T1 ESCC. The model demonstrated good discriminative ability (AUC 0.858, 95%CI 0.826-0.890). After mIF staining of 28 prospectively collected T1 ESCC tissue samples, we observed that microvessels and lymphatic capillaries were abundant in the mucosa in lymph node-positive samples but not in lymph node-negative samples. In addition, the average density of FOXP3 + T cells in samples with and without metastasis was 253/mm 2 and 26/mm 2 (P < 0.001), and the average density of CD8 + T cells was 112/mm 2 and 432/mm 2 (P < 0.001) in quantitative analysis, respectively. Conclusions: This study (RENMIN-237) developed a well-performing LNM risk stratification model of T1 ESCC to reduce both overtreatment and undertreatment, and we found that FOXP3 + T cells in the tumor microenvironment are a risk factor for LNM, while CD8+ T cells can serve as a protective factor against LNM.

Novel Approaches to Precisely Estimate Prognostic Significance of Metastatic Lymph Nodes and Adequacy of Lymphadenectomy on Esophageal Squamous Cell Carcinoma Patients: Beyond the Tip of the Iceberg

Prognostic Significance of Preoperative Lymph Node Assessment for Patients with Stage Pn0 Esophageal Squamous Cell Carcinoma after Esophagectomy.

A modified survival model for patients with esophageal squamous cell carcinoma based on lymph nodes: A study based on SEER database and external validation

Log Odds of Positive Lymph Nodes Predicts Survival in Patients after Resection for Esophageal Cancer.

Comprehensive analysis of prognostic value of lymph node classifications in esophageal squamous cell carcinoma: a large real-world multicenter study

Prognostic prediction and comparison of three staging programs for patients with advanced (T2-T4) esophageal squamous carcinoma after radical resection

Development of a Novel Biomarker Model for Predicting Preoperative Lymph Node Metastatic Extent in Esophageal Squamous Cell Carcinoma1.

Prognostic Impact of Lymph Node Harvest for Patients with Node-Negative Esophageal Squamous Cell Carcinoma: a Large-Scale Multicenter Study

Comparative Analysis of Methodologies for Predicting Overall Survival in Patients with Non‐small Cell Lung Cancer Based on the Number and Rate of Resected Positive Lymph Nodes: A Study Based on the SEER Database for 2010 Through 2019

Prediction of lymph node status in stage T1 esophageal squamous cell carcinoma.

A Modified N Stage Method Considering Negative Lymph Node and Positive Lymph Node for Esophagus Cancer Evaluation

The Minimum Number of Examined Lymph Nodes for Accurate Nodal Staging and Optimal Survival of Stage T1-2 Esophageal Squamous Cell Carcinoma: A Retrospective Multicenter Cohort with SEER Database Validation

A Novel Multivariate Scoring System for Determining the Prognosis of Lymph Node-Negative Esophageal Squamous Cell Carcinoma Following Surgical Therapy: an Observational Study

Patterns of regional lymph node metastasis predict postoperative overall survival and disease-free survival in locally advanced esophageal squamous cell carcinoma

Effect of lymph node examined count on accurate staging and survival of resected esophageal cancer.

Prognostic impact of examined lymph-node count for patients with esophageal cancer: development and validation prediction model

The Positive Lymph Node Ratio Predicts Long-Term Survival in Patients with Operable Thoracic Esophageal Squamous Cell Carcinoma in China

Clinical models to predict lymph nodes metastasis and distant metastasis in newly diagnosed early esophageal cancer patients: A population‐based study

Postoperative Survival Effect of Examined Lymph Node Count in Node-Negative Esophageal Carcinoma

Development of a Novel Serum Exosomal MicroRNA Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma

A Model Shows Utility in Predicting Postoperative Recurrence and Distant Metastasis in Curatively Resected Esophageal Squamous Cell Cancer.